Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies

BACKGROUND: The stimulant methylphenidate (MPH) has been a mainstay of treatment for attention-deficit/hyperactivity disorder (ADHD) for many years. Owing to the short half-life and the issues associated with multiple daily dosing of immediate-release MPH formulations, a new generation of long-actin...

Descripción completa

Detalles Bibliográficos
Autores principales: Coghill, David, Banaschewski, Tobias, Zuddas, Alessandro, Pelaz, Antonio, Gagliano, Antonella, Doepfner, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852277/
https://www.ncbi.nlm.nih.gov/pubmed/24074240
http://dx.doi.org/10.1186/1471-244X-13-237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852277/
https://www.ncbi.nlm.nih.gov/pubmed/24074240
http://dx.doi.org/10.1186/1471-244X-13-237

Ejemplares similares